Literature DB >> 23812658

Human chorionic gonadotropin increases β-cleavage of amyloid precursor protein in SH-SY5Y cells.

Soheila Saberi1, Yan Ping Du, MacDonald Christie, Claire Goldsbury.   

Abstract

Elevated levels of amyloid-β (Aβ) peptides, the main component of amyloid plaques in Alzheimer's disease, are the result of excessive β- and γ-cleavage of the amyloid precursor protein (APP) and/or impaired Aβ clearance in the brain. It has been suggested that high concentrations of luteinizing hormone (LH) in women contribute to increased Aβ generation after menopause, but the mechanism for this is incompletely understood. We investigated the effect of human chorionic gonadotropin (hCG), an LH receptor agonist, on APP β-cleavage in the SH-SY5Y neuroblastoma cell line. Treatment of these cells with hCG-induced elevated β-cleavage in a dose-dependent manner: administration of 30 mIU but not 10 mIU/ml of hCG significantly increased sAPPβ levels in the cell medium 1.7-fold as measured by ELISA. These results support the notion that LH contributes to elevated Aβ levels at least in part by increasing β-cleavage of APP by β-site APP cleaving enzyme.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23812658     DOI: 10.1007/s10571-013-9954-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  16 in total

1.  FBL2 regulates amyloid precursor protein (APP) metabolism by promoting ubiquitination-dependent APP degradation and inhibition of APP endocytosis.

Authors:  Tomomichi Watanabe; Yukiko Hikichi; Antje Willuweit; Yasushi Shintani; Takashi Horiguchi
Journal:  J Neurosci       Date:  2012-03-07       Impact factor: 6.167

2.  Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

Authors:  Peter P Zandi; Michelle C Carlson; Brenda L Plassman; Kathleen A Welsh-Bohmer; Lawrence S Mayer; David C Steffens; John C S Breitner
Journal:  JAMA       Date:  2002-11-06       Impact factor: 56.272

3.  Earlier onset of Alzheimer's disease in men with Down syndrome.

Authors:  N Schupf; D Kapell; B Nightingale; A Rodriguez; B Tycko; R Mayeux
Journal:  Neurology       Date:  1998-04       Impact factor: 9.910

4.  Direct exposure of guinea pig CNS to human luteinizing hormone increases cerebrospinal fluid and cerebral beta amyloid levels.

Authors:  Eka J Wahjoepramono; Linda K Wijaya; Kevin Taddei; Kristyn A Bates; Matthew Howard; Georgia Martins; Karl deRuyck; Paul M Matthews; Giuseppe Verdile; Ralph N Martins
Journal:  Neuroendocrinology       Date:  2011-10-05       Impact factor: 4.914

5.  Increases in luteinizing hormone are associated with declines in cognitive performance.

Authors:  Gemma Casadesus; Erin L Milliken; Kate M Webber; Richard L Bowen; Zhenmin Lei; C V Rao; George Perry; Ruth A Keri; Mark A Smith
Journal:  Mol Cell Endocrinol       Date:  2007-02-06       Impact factor: 4.102

6.  CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.

Authors:  R M D Holsinger; J S Lee; A Boyd; C L Masters; S J Collins
Journal:  Neurology       Date:  2006-08-22       Impact factor: 9.910

7.  Effect of chronic hCG administration on Alzheimer's-related cognition and A beta accumulation in PS1KI mice.

Authors:  A M Barron; G Verdile; K Taddei; K A Bates; R N Martins
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

8.  Novel expression of human chorionic gonadotropin/luteinizing hormone receptor gene in brain.

Authors:  Z M Lei; C V Rao; J L Kornyei; P Licht; E S Hiatt
Journal:  Endocrinology       Date:  1993-05       Impact factor: 4.736

9.  Luteinizing hormone, a reproductive regulator that modulates the processing of amyloid-beta precursor protein and amyloid-beta deposition.

Authors:  Richard L Bowen; Giuseppe Verdile; Tianbing Liu; Albert F Parlow; George Perry; Mark A Smith; Ralph N Martins; Craig S Atwood
Journal:  J Biol Chem       Date:  2004-02-09       Impact factor: 5.157

10.  Identification and structural characterization of the neuronal luteinizing hormone receptor associated with sensory systems.

Authors:  Pirjo M Apaja; Kirsi T Harju; Jyrki T Aatsinki; Ulla E Petäjä-Repo; Hannu J Rajaniemi
Journal:  J Biol Chem       Date:  2003-10-27       Impact factor: 5.157

View more
  4 in total

Review 1.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

Review 2.  The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  Horm Behav       Date:  2015-07-16       Impact factor: 3.587

Review 3.  A Unified Hypothesis of Early- and Late-Onset Alzheimer's Disease Pathogenesis.

Authors:  Craig S Atwood; Richard L Bowen
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

4.  Human chorionic gonadotropin attenuates amyloid-β plaques induced by streptozotocin in the rat brain by affecting cytochrome c-ir neuron density.

Authors:  Emsehgol Nikmahzar; Mehrdad Jahanshahi; Leila Elyasi; Mohsen Saeidi; Fatemeh Babakordi; Gozal Bahlakeh
Journal:  Iran J Basic Med Sci       Date:  2019-02       Impact factor: 2.699

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.